What are the criteria for a reactive fetal heart rate (FHR) tracing?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Criteria for a Reactive Fetal Heart Rate Tracing

A reactive FHR tracing requires ≥2 accelerations of ≥15 bpm above baseline, lasting ≥15 seconds, within a 20-minute period in term fetuses (≥32 weeks). For preterm fetuses (<32 weeks), the criteria are modified to ≥2 accelerations of ≥10 bpm above baseline, lasting ≥10 seconds within a 20-minute period 1.

Core Components of Reactivity

The definition of a reactive tracing is based on acceleration criteria that vary by gestational age:

Term Fetuses (≥32 weeks)

  • Accelerations: ≥2 accelerations
  • Amplitude: Rise of ≥15 bpm from baseline
  • Duration: Lasting ≥15 seconds (measured from onset to return to baseline)
  • Time window: Within 20 minutes 1

Preterm Fetuses (<32 weeks)

  • Accelerations: ≥2 accelerations
  • Amplitude: Rise of ≥10 bpm from baseline
  • Duration: Lasting ≥10 seconds
  • Time window: Within 20 minutes 1

Additional Required Features for Normal Tracing

Beyond accelerations, a truly reassuring reactive tracing (NICHD Category I) must also demonstrate 1:

  • Normal baseline FHR: 110-160 bpm
  • Moderate variability: 6-25 bpm (reflects intact central nervous system function)
  • Absence of decelerations: No late or variable decelerations present

Important Clinical Nuances

Duration Criteria Clarification

There are two interpretations of the "15 seconds" duration criterion that affect reactivity rates 2:

  • Short criterion: 15 seconds from beginning of acceleration until return to baseline (more commonly used, yields 89% reactivity)
  • Long criterion: FHR maintained at ≥15 bpm above baseline for entire 15 seconds (more stringent, yields 79% reactivity)

The short criterion is recommended as it maximizes sensitivity without compromising the ability to predict fetal well-being 2.

Gestational Age Considerations

Research demonstrates that 71% of preterm fetuses (25-28 weeks) are reactive using 15 bpm criteria, but this increases to 92% when using 10 bpm criteria 3. This lower threshold for preterm fetuses improves test specificity and reduces false-positive rates, which is why the modified criteria are essential for accurate interpretation before 32 weeks.

Common Pitfalls to Avoid

  1. Sleep cycles: Normal fetal sleep cycles lasting 20-40 minutes can cause temporary loss of accelerations and decreased variability. If no accelerations are present, extend monitoring or use fetal stimulation (acoustic or scalp) before declaring non-reactivity 1.

  2. Medications: Analgesics, anesthetics, barbiturates, and magnesium sulfate can all reduce variability and accelerations without indicating fetal compromise 1.

  3. Isolated non-reactivity with good variability: A non-reactive pattern with moderate variability (≥6 bpm) is NOT equivalent to fetal distress and has similar outcomes to reactive tracings 4. The critical danger sign is absent variability combined with non-reactivity.

Clinical Significance

The presence of accelerations with moderate variability predicts the absence of fetal acidemia (pH ≥7.20) 1. Conversely, if accelerations are absent after fetal stimulation in the setting of minimal or absent variability, this suggests possible fetal hypoxia or acidemia and warrants further evaluation or expedited delivery 1.

A reactive tracing indicates fetal well-being and allows continuation of current monitoring methods, whether structured intermittent auscultation or continuous electronic fetal monitoring 1.

References

Guideline

intrapartum fetal monitoring.

American family physician, 2009

Research

Fetal heart rate characteristics at 25 to 28 weeks' gestation.

American journal of perinatology, 1998

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.